Role of Cerebral Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis.
Arpanjeet KaurArshdeep S DhaliwalSumit SohalDr Yeongjin GwonSoumya GuptaKirtipal BhatiaAbel Casso DominguezCraig BasmanJacqueline E Tamis-HollandPublished in: Journal of the American Heart Association (2024)
The use of CEPD in transcatheter aortic valve replacement was not associated with a statistically significant reduction in the risk of clinical, neurological, and safety outcomes.
Keyphrases
- transcatheter aortic valve replacement
- patients undergoing
- systematic review
- aortic stenosis
- aortic valve
- meta analyses
- subarachnoid hemorrhage
- cerebral ischemia
- case control
- randomized controlled trial
- type diabetes
- metabolic syndrome
- brain injury
- heart failure
- left ventricular
- cerebral blood flow
- glycemic control